The epithelial-derived, type II transmembrane serine protease matriptase, the mouse homologue of which is epithin, has been shown to be involved in epidermal differentiation, hair formation, and thymus function. We show in this study that epithin/matriptase (Epi/ MTP) plays a significant role in mammary epithelial cell growth and morphogenesis. Epi/ MTP is expressed at low level in the mouse mammary epithelium of young animals and it accumulates at the terminal end-bud of the growing ducts. The level of Epi/MTP is elevated in the mammary glands at stages when epithelial proliferation and modeling occur.
Introduction
The postnatal growth, morphogenesis, and differentiation of the mammary gland occur under the cyclic influence of steroids and growth factors (Hennighausen and Robinson, 2005) . In the rodent, mammary ductal elongation during puberty results from the proliferation and penetration of the specialized ductal ''terminal end-buds'' (TEBs) into the surrounding fatty stroma. During pregnancy, there is extensive lateral branching and development of epithelial buds (alveoli) which rapidly grow and organize into a secretory lobular structure in preparation for lactation. the mammary epithelium undergoes apoptosis and returns to a state resembling that of the nulliparous female. This cyclic tissue remodeling also occurs during the estrous cycle, though with more subtle changes. Matrix remodeling and cellular migration play a significant part in these processes.
Urokinase plasminogen activator (uPA)/plasminogen/ matrix metalloproteinase (MMP) (Dano et al., 1985) and hepatocyte growth factor (HGF)/scatter factor (SF) (Stoker et al., 1987) have been proposed to be the major pericellular-degrading protease system and the major motility factor, respectively. HGF/SF is a multi-functional factor that is involved in the mitogenic (Gherardi and Stoker, 1991) , motogenic (Gherardi and Stoker, 1991; Cacci et al., 2003) , and morphogenic (Birnkmann et al., 1995) responses of various cells through its binding to the epithelial surface receptor c-Met (Montesano et al., 1991; Niranjan et al., 1995; Rosen et al., 1997; Gal et al., 1998) . The activation of uPA initiates the extracellular matrix degrading protease cascade including the plasminogen and the zinc-dependent MMP (Dano et al., 1985) . HGF/SF Schmidt et al., 1995; Uehara et al., 1995) and uPA (Mignatti and Rifkin, 1993) have been implicated in normal organ development including the mammary gland (MG), as well as in cancer invasion and metastasis (Andreasen, 1997; Ono et al., 2006) . HGF/SF, uPA and MMP are expressed and secreted by stromal cells as an inactive, single-chain precursor and require proteolysis at a specific site for their conversion to the active, two-chain proteins.
Matriptase is an epithelial-derived, type II transmembrane serine protease, also known as MT-SP1 (Takeuchi et al., 1999) , ST14 or TADG-15 (Tanimoto et al., 2001) , or for the mouse homolog, epithin (Kim et al., 1999) . Epithin/matriptase (Epi/ MTP) is present on the surface of a broad range of epithelial cells (Oberst et al., 2001 (Oberst et al., , 2003 . Proteolytic substrates of Epi/ MTP uncovered in recent years show that Epi/MTP has roles in diverse cellular activities and pathological processes. It converts prostasin zymogen, a glycosylphophatidylinositolanchored membrane serine protease, to an active two-chain form, which subsequently contributes to epidermal terminal differentiation (Netzel-Arnett et al., 2006; List et al., 2007) . Epi/MTP expressed on monocytes can activate proteaseactivated receptor-2 on the endothelial cell surface suggesting that Epi/MTP may be involved in cell-cell interactions during atherosclerosis (Seitz et al., 2007) . It is also an efficient and specific activator of uPA-receptor-bound uPA on the surface of monocytes (Kilpatrick et al., 2006) ; through which it might participate in fibrinolysis. Epi/MTP expressed on peritoneal macrophages cleaves and activates macrophage stimulating protein-1 resulting in inhibition of nitric oxide production (Bhatt et al., 2007) . We have shown that Epi/MTP can cleave the latent form of HGF/SF and the latent form of uPA to convert them to their functionally active proteins (Lee et al., 2000b) . Activation of these two proteins conceivably can activate cell migration and/or ECM degradation, through which Epi/MTP could play roles in tissue remodeling, cancer cell invasion and metastasis. Other molecules such as MMP3 , insulin-like growth factor binding protein-related protein-1 (Ahmed et al., 2006) , Trask (Bhatt et al., 2005) and vascular endothelial growth factor receptor-2 (Darragh et al., 2008) have all been shown to be cleaved by Epi/MTP. Epi/MTP is expressed in breast cancer cells and nontumorigenic breast epithelial cells (Oberst et al., 2001) . High levels of Epi/MTP expression (Oberst et al., 2001 ) and deregulation of Epi/MTP activation (Benaud et al., 2002a) are shown to associate with the growth and metastasis of breast cancer. Its role in normal MG function, however, is less understood. Although originally purified from human milk (Lin et al., 1999) , the expression or the function of Epi/MTP in mammary epithelium has not been carefully investigated. In the present study, we examine the role and the mechanism of matriptase/ epithin in mammary gland development. We show that Epi/ MTP is involved in mammary epithelial growth and morphogenesis through action of its proteolytic substrate HGF/SF.
2.
Results and discussion 2.1. Expression of Epi/MTP mRNA in the mouse mammary epithelium changes during postnatal development
To investigate the function of Epi/MTP in MG, the cellular distribution of Epi/MTP during postnatal development was examined. In situ hybridization using the DIG-labeled riboprobes was used in these studies. Staining with the anti-sense riboprobe showed that Epi/MTP mRNA in the mammary epithelium was generally low during puberty. In the 3-week old mammary epithelium (Fig. 1A) , positive staining of Epi/MTP anti-sense probe was found in both the ducts (Fig. 1A , dotted lines) and TEBs (Fig. 1A, dark circle) . This staining, however, was only slightly above the negative staining of the sense probe (compare Fig. 1A-B ). In the 5-week old nulliparous MG, some epithelial cells showed strong anti-sense riboprobe staining (Fig. 1D , large dotted lines) while many cells were low or negative (Fig. 1D, small dotted lines) . Interestingly, high level accumulation of Epi/MTP mRNA in the 5-week old MG was detected mostly in the TEBs (Fig. 1D , shown with dark circles), the actively growing portion of the ducts. Both the cap cells (small arrows in Fig. 1D 0 and D 0 0 ) and the body cells (large arrows in Fig. 1D 0 and D 0 0 ) of the TEBs were positively stained. In the adult female animals, strong expression of Epi/MTP mRNA was detected in the mammary ductal epithelium of virgin animals ( Fig. 2A ). In the pregnant animals, both ductal ( Fig. 2D , arrows) and lobular epithelium (Fig. 2D , arrowhead and the inset in Fig. 2D ) highly expressed Epi/MTP mRNA. Consistent with its being an epithelial-derived molecule (Oberst et al., 2001) , little staining was found in the fat tissue (Fig. 2) . The high background staining in the stroma of young animal (Fig. 1A ) is likely to be non-specific chromogen precipitation due to over-incubation with the substrate since the same background was also seen in section hybridized with the sense probe (Fig. 1B) . Cells that we could clearly identify as myoepithelial cells under high magnification microscopy were negative for Epi/MTP anti-sense staining ( Fig. 2G and H, drawn in red). Because none of the Epi/MTP antibodies we have tested worked well on mouse mammary glands immunohistochemistry, co-stain of Epi/MTP with myoepithelial marker was impossible. Nevertheless, immunostaining with smooth muscle actin (SMA) alone confirmed that cells that were identified to be Epi/MTP negative cells were indeed myoepithelial cells (Fig. 2I, arrows) . Thus, in contrast to its To assess the expression pattern of Epi/MTP mRNA during postnatal mammary development, mammary tissues were collected from FVB mice at 10 different time points during postnatal development. These time points span key events including those at the onset of puberty (3-week old), during puberty (5-week old), after puberty (12-week old), during pregnancy (days 6.5, 10.5, and 17.5), during lactation (days 2.5 and 9.5), and post-lactational involution (days 2 and 9 post weaning). The level of Epi/MTP transcripts in the various stages was compared quantitatively by real-time PCR. Fig. 3 showed graphic presentation of the relative changes of Epi/MTP mRNA at different postnatal developmental time points. When normalized to the expression of the reference gene GAPDH, Epi/MTP mRNA levels in MG were modulated in concert with the growth and remodeling of the mammary epithelium (Fig. 3A) . Since Epi/MTP mRNA was detected only in the mammary epithelial cells (Fig. 1) , the epithelial cell molecule cytokeratin 8 (CK8) real-time was used to normalize mammary epithelial expression of Epi/MTP mRNA. Fig. 3B showed the changes of Epi/MTP in epithelium at each developmental time point after normalization to that of the 3-week old animals. The pattern of Epi/MTP normalized to CK8 resembled that of Epi/MTP normalized to GAPDH, supporting previous observation that Epi/MTP is expressed mostly in the epithelial cells. Consistent with the results from in situ hybridization, there was a low level of epithelial Epi/MTP mRNA in pre-pubertal (3 wk) and pubertal (5 wk) animals which increased twofold in the 12-week nulliparous mammary gland and remained steady in the early and mid-pregnant mice (6.5P and 10.5P). Another twofold increase of epithelial Epi/MTP mRNA occurred in late pregnancy (17.5P). The greatest increase (over 11-fold that of pre-puberty) of epithelial Epi/MTP mRNA was seen at 9.5-day lactation (9.5L). The Epi/MTP mRNA in the epithelium declined with weaning (2I) to a level similar to that in the nulliparous adult.
2.2.
Expression of Epi/MTP protein in the mouse mammary epithelium changes during postnatal development Whole mammary gland lysates were further evaluated for Epi/MTP and cytokeratin protein expression by Western blot. These assays were used to determine the coordination between RNA synthesis and protein abundance of Epi/MTP in the mammary epithelium. Epi/MTP is present either as the full-length protein of about 95 kDa or as the N-terminal processed protein of 85-72 kDa (Cho et al., 2001; Kiyomiya et al., 2006; Lee et al., 2007) . When activated by a single proteolytic cleavage at the protease domain, it becomes a twochain molecule connected by a disulfide bond (Cho et al., 2001; Benaud et al., 2002b) . Upon treatment with reducing agent, the activated two-chain form separates into two fragments: the C-terminal protease domain of about 30 kDa and the N-terminal non-protease domain of about 65 kDa containing two CUB and four LDLR domains (Cho et al., 2001; Kiyomiya et al., 2006) . Since a single band of about 80 kDa was detected in all MG tissue extracts boiled in protein gel sample buffer without reducing agent, Epi/MTP in MG tissue is evidently present mostly in the N-terminal processed form. Epi/MTP protein was below the limit of Western blot detection in pre-pubertal animals, elevated in pubertal, post-pubertal and pregnant animals, reached its highest level in lactation and declined in involution (Fig. 4A, top panel) . The pattern of Epi/MTP expression correlated well with changes in epithelial content as shown in Western blot with antibody to CK8 and cytokeratin 18 (CK18) (Fig. 4A , lower panel). Changes of Epi/MTP protein in the mammary epithelium ( Fig. 4B ) closely matched its mRNA expression profile (Fig. 3B ), however differed at several points. The level of Epi/MTP protein ( Fig. 4B ) in the 5-week, 12-week and in the 6.5-day pregnant mammary glands rose more rapidly and more profoundly than the mRNA transcript ( Fig. 3D) , implying that at these stages of mammary epithelial development, an increasing epithelial level of Epi/MTP protein is achieved by both increasing gene expression and protein stability with the latter having a larger effect than the former. These observations also implied that Epi/MTP is directly involved in mammary epithelial modeling. The epithelial level of Epi/MTP protein in mid-and late-pregnant MG (10.5P and 17.5P) and also in the early lactating MG (2.5L) dropped steadily despite an increase in epithelial Epi/ MTP mRNA (Fig. 3B ). Since the level of Epi/MTP was normalized to the luminal epithelial marker proteins CK8 and CK18, the effect of milk protein during lactation was eliminated. Fast protein turnover thus, appears to be responsible for lowering the Epi/MTP level in the mid-to-late pregnant and in the early lactating mammary epithelium. Mammary epithelial Epi/MTP protein, followed the changes in its mRNA level and was elevated again in the 9.5-day lactating mammary glands (Fig. 4B ) and declined as mammary glands entered post-lactational involution.
Cumulatively, these data demonstrated that mammary gland epithelial expression of Epi/MTP is regulated during postnatal mammary development. Its accumulation at the TEBs in puberty, its expression in luminal cells in mature mammary epithelium, and its up-regulation during the peri- was further normalized to that in the 3-week old mammary epithelium. 3wk, 3-week old; 5wk, 5-week old; 12wk, 12-week old; 6.5P, 6.5-day pregnancy; 10.5P, 10.5-day pregnancy; 17.5P, 17.5-day pregnancy; 2.5L, 2.5-day lactation; 9.5L, 9.5-day lactation; 2I, 2-day post-lactational regression and 9I, 9-day post-lactational regression.
ods when increasing proliferation of epithelial cells occurs suggest that Epi/MTP is involved in ductal elongation and branching. Epi/MTP has been shown to directly activate the latent forms of HGF (Lee et al., 2000b) , uPA (Lee et al., 2000b; Takeuchi et al., 2000) and MMP3 in vitro. uPA mRNA is expressed in mammary epithelium of nulliparous adult, early and mid-pregnancy, is subsequently down regulated during lactation, and reappears during involution (Busso et al., 1989) . MMP3 is detected at high levels between 5 and 10 weeks of age and during early pregnancy reaching peak level at day 6 of pregnancy (Witty et al., 1995) . It is localized in the stromal component surrounding the growing duct and developing alveoli (Witty et al., 1995) . Both uPA and MMP3 expression overlap partly with Epi/MTP expression. In addition, the epithelial pattern of Epi/MTP protein expression during mammary development is very similar to the mRNA expression profile of stromal factor HGF and of its epithelial receptor c-met (Niranjan et al., 1995) . Considering that HGF/ SF (Lee et al., 2000b) , uPA (Lee et al., 2000b; Takeuchi et al., 2000) (Kilpatrick et al., 2006) and MMP3 all are proteolytic substrates of Epi/MTP, it is likely that Epi/ MTP participates in mammary gland epithelial growth in part through activation of these molecules.
2.3.
Pro-HGF-stimulated morphogenesis of mammary epithelial EpH4/K6 cells in 3D culture is inhibited by sunflower trypsin inhibitor 1 (SFTI1)
HGF is a potent cytokine for mammary epithelial growth and morphogenesis (Niranjan et al., 1995) . We asked whether Epi/MTP participates in mammary epithelial growth or morphogenesis by activating HGF. Epi/MTP-knockdown mice die after birth ; use of these animals for MG development studies is problematical. We thus turned to ex vivo three-dimensional culture of mammary epithelial cells. We used the K6 subline of the EpH4 (EpH4/K6) spontaneously immortalized mouse mammary epithelial cell line (Niemann et al., 1998) . EpH4/K6 cells express several luminal epithelial markers (Lee, unpublished observations) and exhibit morphological and functional characteristics typical of normal mammary epithelial cells. EpH4/K6 cells have been shown to grow into complex three-dimensional structures on isolated basement membrane and to exhibit morphogenic response to growth factor stimulation (Niemann et al., 1998) .
Using an antibody against the N-terminal extracellular domain of human matriptase (Santa Cruz, sc48830), two forms of Epi/MTP protein were detected in EpH4/K6 cells (Fig. 5) . A single protein of 72 kDa was detected in cell lysates in the absence of reducing agent (Fig. 5 , lane 1) whereas boiling in reducing agent produced a second 55 kDa protein fragment (Fig. 5, lane 2) . Evidently, EpH4/K6 cells express both the 72 kDa N-terminal processed, latent protein and the activated two-chain Epi/MTP whose N-terminal non-protease domain of about 55 kDa fragment was detected by the antibody used in the present study.
EpH4/K6 mouse mammary epithelial cells cultured on the basement membrane ECMatrix gel in serum-free basal medium (see Experimental procedures for the components), similar to that reported by Niemann et al. (1998) , formed mostly solid spheroids smaller than 50 lm in diameter (Fig. 6A ) Niemann et al., 1998) . The addition of latent form HGF (pro-HGF) (Fig. 6B-F) , cells grew rapidly and produced many large spheroids with a center lumen (lobule-like structures, Fig. 6C-F, arrowheads) . Some of these lobule-like spheroids had tubular outgrowths (Fig. 6C-G, arrows) ; they are either single lobule with duct projecting (Fig. 6D ), or two (Fig. 6C ) or multiple lobules (Fig. 6F) connected by ducts. A few of colonies had ducts extending several hundred lm in length (Fig. 6B, arrow) . Many colonies also formed multi-lobular structures without an obvious tubular connection (Fig. 6E) . Addition of a potent peptide inhibitor for Epi/MTP, SFTI1 (Long et al., 2001) , to the culture medium inhibited the formation of complex three-dimensional structures, resulting in mostly small solid spheroids (Fig. 6G ) resembling those shown in Fig. 6A when cells were cultured in basal medium (Fig. 6A) . Fig. 7 graphed the statistical distribution of the three-dimensional structures from three independent experiments. Cells cultured in the serum-free basal medium were all aggregates without lumens, 90% of which were smaller than 50 lm in diameter (Fig. 7, Bassal) . In the presence of pro-HGF (Fig. 7,  proHGF) , over 60% of the colonies underwent rapid growth and morphogenesis and formed large lobules with lumens. Almost half of these lobules contained tubular structures, among which about 6% had extended length of several hundred lm, consistent with previous observation that HGF induces the formation of tubular structures (Niemann et al., 1998) . The extent of morphological change stimulated by the addition of pro-HGF was similar to the effect stimulated by a fully activated HGF preparation (Fig. 7, aHGF) . Clearly, a protease activity is present in the system that is responsible for the activation of pro-HGF stimulating EpH4/K6 cells morphogenesis. Peptide inhibitor SFTI1 significantly reduced the effect of pro-HGF: only 15% of the colonies underwent morphogenesis, and the number of tubule-containing colonies was reduced to less than 10% (Fig. 7 , proHGF + SFTI1). SFTI1 had little effect on the morphological changes stimulated by the addition of a fully activated HGF (Fig. 7 , aHGF + SFTI1) suggesting the effect is specific to the molecule that activates pro-HGF. Inhibition of tubular and lobular growth on ECMatrix was not due to inhibition of cell growth since SFTI1 did not affect the proliferation of EpH4/K6 cells (Fig. 8) . Taken together, these studies demonstrated that a protease, possibly Epi/MTP plays a key role in pro-HGF activation during mammary epithelial growth and modeling. Its action is inhibited by SFTI1.
Beside Epi/MTP, proteases capable of activating pro-HGF include uPA (Naldini et al., 1992 (Naldini et al., , 1995 , hepsin (Kirchhofer et al., 2005) , HGF activator (HGFA) and its homologous protein blood coagulation factor XII (Shimomura et al., 1995) . ECM is known to contain uPA and MMPs, and EpH4/K6 cells do express the HGFA transcript (Lee's unpublished observation). The amount of SFTI1 added to our 3-dimensional culture was 20 lM which is more than 20,000-fold of its Ki to Epi/ MTP, but 250-fold below its Ki (500 lM) to uPA (Long et al., 2001) . This amount of SFTI1 should be sufficient to block Epi/MTP enzyme activity but not uPA. Addition of SFTI1 almost completely eliminated the pro-HGF activation-dependent morphogenesis of mammary epithelial cells in 3-dimensional culture, thus the involvement of uPA in pro-HGF activation in ECMatrix cultures is unlikely. Although our tests did not entirely exclude the effect of SFTI1 inhibition on other HGF-activating proteins during EpH4/K6 cell morphogenesis, SFTI1 does appear to have a narrow specificity. This serine protease inhibitor that was originally identified as a potent trypsin inhibitor (Ki of 0.1 nM) (Luckett et al., 1999) can only inhibit Epi/MTP (Ki of 0.92 nM) (Long et al., 2001 ) and cathepsin G (Ki < 0.15 nM) (Luckett et al., 1999 ) with a potency comparable to trypsin. It is a poor inhibitor of uPA and thrombin (Long et al., 2001 ) and does not inhibit factor Xa (Luckett et al., 1999) . These well described characteristics support our observations that in the Eph4/K6 ECMatrix cultures SFTI1 may well be inhibiting the protease activity of Epi/MTP.
Knockdown of Epi/MTP eliminates pro-HGFstimulated morphogenesis of mammary epithelial EpH4/K6 cells
The involvement of Epi/MTP in EpH4/K6 cell morphogenesis in three-dimensional culture was further investigated with small interference RNA (siRNA) knockdown of Epi/MTP. When cultured in basal medium (Fig. 9A, Basal) , EpH4/K6 cells transfected with either a non-silencing control siRNA (Fig. 9, siNeg) Fig. 7 -Statistical analysis of mouse mammary epithelial cell morphogenesis in ECMatrix 3-D culture. EpH4/K6 cells cultured in serum-free basal medium (Basal), in basal medium containing pro-HGF (proHGF), in basal medium containing both pro-HGF and SFTI1 (proHGF + SFTI1), in basal medium containing the active form of HGF (aHGF) and in basal medium containing active form of HGF and SFTI1 (aHGF + SFTI1). Cells were stained and confocal images were collected from the 3-D cultures as described in Fig. 6 . The 3-D colonies were classified into six types of morphology as described in Experimental procedures. Data were gathered from three independent experiments and presented as the ratio of the percentage of each colony type to the total number in each of six types of colonies. aggre w/o lumen: aggregate without lumen, aggre w/lumen: aggregate with lumen. * p 6 0.01, ** p 6 0.005, *** p = 0.08. or the Epi/MTP specific siRNA (Fig. 9A, siMTP) grew mostly aggregates without lumen (about 80% from the siNeg-transfected cells and 84% from the siMTP-transfected cells) and only a few lobular or ductal colonies. The non-silencing control siRNA-transfected cells underwent significant morphogenic growth in the presence of pro-HGF and left only about 28% as aggregates without a lumen while the majority of colonies formed alveoli or ducts. About 51% of the colonies had tubular structures (a fourfold induction), and 7% of which were long tubules (Fig. 9A , siNeg + proHGF). Cells with Epi/ MTP-knockdown showed much less morphogenic response to pro-HGF (Fig. 9A , siE/M + proHGF). Over 70% of the colonies from these cells remained as aggregates without lumens, most of which were smaller than 50 lm in diameter (Fig. 9A , siE/M + proHGF). Only about 11% of the colonies formed tubular structures. Evidently, EpH4/K6 cells lacking Epi/MTP lost their ability to undergo morphogenesis due to incapable of activating pro-HFG.
Epi/MTP-knockdown cells developed a few morphologically advanced colonies when cultured with pro-HGF: about 8% more lobular structures and about 3% more tubular structures than they were grown in basal medium: This might be because Epi/MTP siRNA, although significantly reduced, did not completely eliminate the Epi/MTP transcript (Fig. 9B) . Cells that still have expression of Epi/MTP activate pro-HGF to induce morphogenesis at a lower level. It is also possible that there are other HGF-activating molecules present in the cells that contributed to the formation of these colonies. As we had mentioned earlier, HGFA mRNA was detected in EpH4/ K6 cells. siRNA-transfected EpH4/K6 cells cultured in basal medium (Fig. 9 , siNeg, siMTP in basal medium) developed more lobular and tubular structures than those shown in Fig. 7 . This might be due to variations between different batches of ECMatrix. It is possible that the ECMatrix used in culture of siRNA-transfected cells contains factors promoting low level of morphogenesis. This could also contribute to the appearance of low level of morphologically advanced colonies in Epi/MTP-knockdown cultures treated with pro-HGF (siE/ M + proHGF). HGF is shown to induce EpH4/K6 cells growth and tubular structure formation (Niemann et al., 1998) . Addition of pro-HGF in EpH4/K6 cells significantly induced the formation of complex three-dimensional structures including single lobular structures, tubular structures (both ductal lobules and long ducts) and some multi-lobular structures. EpH/ K6 cells without stimulation, although expressed active form of Epi/MTP, did not undergo extensive morphogenesis. Knockdown of Epi/MTP or treatment with SFTI1 greatly reduced the number of ductal lobules and long ducts and fewer changes on the number of multi-lobular structures even in the presence of pro-HGF. Thus, Epi/MTP likely plays important roles in HGF activation during mammary epithelium morphogenesis.
The involvement of Epi/MTP in mammary epithelial function has been speculated but there are no studies investigating its role or mechanism in normal mammary gland functions. Our study is the first to examine and quantify the expression of Epi/MTP during mammary epithelial development. These studies demonstrate that the expression pattern of Epi/MTP correlates with mammary epithelial modeling. Epi/MTP is accumulated in the TEBs of pubertal mammary glands and is mainly expressed by the luminal epithelial cells in mature mammary glands. Its expression and cellular localization in mammary gland place Epi/MTP in position to directly activate extracellular matrix degradation and growth factors for mammary epithelial cell migration and morphogenesis, indicating that its role in tissue modeling is significant. We show that Epi/MTP executes its function in mammary epithelial morphogenesis and growth through activation of pro-HGF. It is conceivable that either deregulation of Epi/MTP activity or up-regulation of Epi/MTP expression may induce localized abnormal activation of pro-HGF in mammary epithelium and to direct breast cancer tumorigenesis or progression. The role of HGF and its receptor c-Met in cancer is well established (Jeffers et al., 1996) . HGF, c-Met and Epi/MTP are co-expressed in breast cancers, and a high level of c-Met and Epi/MTP is associated with more aggressive tumors (Kang et al., 2003) . It has also been shown that Epi/MTP is constitutively activated in breast cancer cell lines (Benaud et al., 2002a) whilst its activation in non-transformed breast epithelial cells is stimulated by sphingosine 1-phosphate (Benaud et al., 2002b) . The findings in our present studies signify the role of Epi/MTP as an upstream activator in normal mammary epithelial modeling; aberrance of its function is linked to breast cancer. This is consistent with the recent trend in cancer biology that the developmental/ homeostatic mechanisms are hijacked in tumorigenesis and cancer. Epi/MTP could be a target in breast cancer prevention and therapy.
3.
Experimental procedures 3.1. Materials
Enzymes and reagents for RNA works
DNAse I, T7 and SP6 RNA polymerases, RNAse-inhibitor, pSPT19 plasmids, the digoxigenin (DIG)-UTP RNA in vitro transcription labeling mix, nitroblue tetrazolium chloride (NBT) and 5-bromo-4-chloro-3-indolyl phosphate (BCIP) were purchased from Roche (Indianapolis, IN, USA). TRIzol reagent, phenol:chloroform (1:1) solution, RNAse H, Superscript III reverse transcriptase and oligo(dT) 12-18 primers were purchased from Invitrogen (Carisbad, CA, USA). TaqMan primers and probes (TaqMan Ò MGB probe, FAM TM dye-labeled) of ABI Assays-on-Demand TM Gene Expression Assay Mix for ST14, GAP-DH, and KRT2-8 (cytokeratin 8) and the TaqMan Universal PCR Master Mix were from Applied Biosystems (Foster City, USA). HiPerFect transfection reagent, the small interfering RNA (siRNA) against mouse St14 and a non-silencing control siRNA were purchased from (QIAGEN, Valencia, CA).
Cell culture reagents
Dulbecco's modified Eagle's medium (DMEM) and fetal calf serum (FCS), were from Invitrogen (Carlsbad, CA, USA). ECMatrix, a solid gel of basement proteins prepared from the Engelbreth Holm-Swarm mouse tumor, was from Chemicon International Inc. (Temecula, CA, USA). Sunflower trypsin inhibitor 1 (SFTI1) is a synthetic peptide described previously (Long et al., 2001) . The latent, single-chain HGF/SF (about 80% of this preparation is the inactive, single-chain form of latent HGF (Lee et al., 2000b ) was a generous gift from Dr. George Vande Woude (Van Andel Institute, Grand Rapids, MI, USA). The active HGF was purchased from Calbiochem (Gibbstown, NJ). Insulin was purchased from BioFluid; hydrocortisone and prolactin were from Sigma (St. Louis, MR, USA).
Antibodies and chemicals
Rat anti-E-cadherin antibody and FITC-conjugated anti-rat antibody were purchased from Zymed (South San Francisco, CA). Rabbit polyclonal anti-matriptase antibody (H270) against the N-terminal extracellular domain of the shed matriptase of human origin was purchased from Santa Crutz Biotechnology Inc. (Santa Cruz, CA, USA). Anti-epithin antibody is a rabbit polyclonal antibody against GST-epithin fusion protein (Cho et al., 2001) . Paraformaldehyde solution was purchased from Electron Microscopy Sciences (Haffield, PA, USA) and 20· SSC was purchased from Invitrogen. All the other chemicals were from Sigma (St. Louis, MR, USA).
Methods

Mouse mammary tissue preparations
Female FVB mice were euthanized by CO 2 asphyxiation followed by cervical dislocation. The numbers 4 and 5 (inguinal) MG were collected from animals at ten different stages during postnatal mammary development: the onset of puberty (3-week), during puberty (5-week), after puberty (12-week), during pregnancy (days 6.5, 10.5, and 17.5), during lactation (days 2.5 and 9.5), and post-lactational involution (days 2 and 9 post weaning). The glands were immersed immediately in 4% paraformaldehyde/phosphate buffer saline (PBS) fixative solution and incubated for 4 h with agitation. Paraformaldehyde fixed tissues were washed in PBS before taken through a short dehydration procedure in graded alcohols. Tissues were then embedded in paraffin; serials tissue sections were cut at 4 lm for in situ hybridization assay. The contralateral MG was frozen immediately in liquid nitrogen for protein and RNA preparation at a later time.
RNA probe preparation and in situ hybridization
Mouse Epi/MTP cDNA was cloned into pSPT19. Purified plasmids were linearized with appropriate restriction enzyme and used as template for synthesis of the sense or anti-sense riboprobes using DIG RNA labeling kit (Roche) according to the manufacturer's protocol. DIG-labeled riboprobes were purified by alcohol precipitation to remove the unincorporated nucleotides. The quality of the probes was analyzed by non-denaturing agarose gel electrophoresis. The yield of labeled probes was estimated by spotting serial dilutions of transcripts onto a nitrocellulose membrane, followed by incubation with anti-DIG alkaline phosphatase-labeled antibody and visualization with NBT/BCIP. A known labeled RNA provided in the kit was used as a standard.
In situ hybridization was performed following a standard procedure (Oberst et al., 2001 ) with some modifications. In brief, serial 4 lm tissue sections were dewaxed in xylene and rehydrated. After treatment with 0.2 N HCl, tissue slides were post-fixed with 4% paraformaldehyde, washed with PBS containing 0.1% DEPC then incubated 10 min in 4· SSC. Tissue sections were prehybridized for 30 min at 56°C in buffer containing 40% deionized formamide, 10% dextran sulfate, 10% Danhardt's solution, 500 lg/ml tRNA and 40 lg/ml denatured salmon sperm DNA. The hybridization step was performed overnight at 56°C in the same buffer with 10 ng DIG-labeled sense or anti-sense riboprobe. Post-hybridization washing was carried at 42°C consecutively with one wash of 4· SSC, two washes of 2· SSC, two washes of 1· SSC, two washes of 0.1· SSC then Tris buffer saline (TBS, pH 7.6). After blocking with 2% horse serum in TBS, the bound DIG-labeled RNA probes were detected with an alkaline-phosphatase-conjugated anti-DIG antibody followed by incubation of NBT/ BCIP. Tissue sections were mounted in aqueous mounting solution and imaged with an Olympus IX71 microscope.
Immunohistochemical staining of paraffin embedded tissue sections
Immunohistochemical staining was performed using DAKO EnVision + kit (DakoCytomation, Inc., Carpinteria, CA, USA) following the manufacture's protocol. In brief, serial 4 lm tissue sections were dewaxed in xylene, rehydrated then heated in 10 mM citrate (pH 6.0) for antigen retrieval. After blocking the endogenous peroxidase with hydrogen peroxide, tissue sections were washed and then incubated with primary antibody. After washing, tissue sections were incubated with the 2nd antibody conjugated with peroxidase-labeled polymer, washed and then incubated with DAB (3 0 ,3 0 -diaminobenzidine) substrate-chromogen solution. Cell nuclei were counterstained with hematoxylin.
RNA preparations
To extract total RNA, individual MG were ground in TRIzol reagent with a motorized pellet pestle. The tissue homogenates were mixed with chloroform by vortex and then centrifuged. Total RNA was recovered from the aqueous phase by isopropanol precipitation. Genomic DNA was removed by a 15-min treatment with DNase I at 37°C. After heat inactivation, DNAse I was removed by phenol:chloroform (1:1) extraction, and RNA was recovered by alcohol precipitation. RNA integrity was assessed by electrophoresis and RNA concentration was measured with a NanoDrop ND-1000 spectrophotometer (Thermo Scientific, Waltham, MA, USA). The average RNA purity (260/280 nm) was greater than 1.9. Eight 3-week old animals and at least five animals each of the other ages were used for RNA preparation.
RT-PCR and real-time PCR
Equal amounts of total RNA isolated from individual MG tissue were pooled together and used as the template in cDNA synthesis. A sufficient amount of cDNA for all the genes in one real-time PCR reaction was synthesized using Superscript III reverse transcriptase and oligo(dT) primers at 50°C for 2 h. cDNA synthesis was stopped by heat inactivation at 70°C for 15 min, the RNA in the RNA/DNA hydride was digested with RNase H at 37°C for 20 min. The resulting cDNA was then used in PCR reactions.
All real-time PCR was performed on a PRISM 7500 HT ABI platform using TaqMan primers and probes (TaqMan Ò MGB probe, FAM TM dye-labeled) of ABI Assays-on-Demand TM Gene Expression Assay Mix in conjunction with the TaqMan Universal PCR Master Mix. GAPDH was used as an endogenous control to normalize the amounts of cDNA used in real-time PCR assay. Cytokeratin 8 (CK8) was included as the reference gene for epithelial cells. Each sample was run in triplicate.
Three sets of real-time PCR data were collected. Data were presented in DC t (changes of threshold cycle) which determines the fold change in gene expression related to the expression of reference gene.
RNA interference
Specific siRNA targeted against mouse St14 mRNA and a non-specific siRNA which has no target were purchased from Qiagen (QIAGEN, Valencia, CA). Transfection of siRNA was performed using HiPerFect (QIAGEN, Valencia, CA) for 72 h following the manufacture provided protocol. Efficiency of Epi/ MTP-knockdown was checked by RT-PCR.
Mammary epithelial cell culture
The K6 subline of mouse mammary epithelial EpH4 cells (EpH4/K6), a generous gift of Dr. Birchmeier (Max-Planck Institute, Berlin) (Niemann et al., 1998) , was routinely maintained in monolayer culture in DMEM supplemented with 10% heatinactivated FCS. For three-dimensional culture, Lab-Tek II eight-chamber glass culture slides (Nalge Nunc Thermo Scientific, Rochester, NY, USA) were coated with ECMatrix solution. About 6500 EpH4/K6 cells were seeded in each chamber in DMEM containing 10% serum. After one day of culture medium was aspirated and replaced with freshly prepared basal medium consisting of serum-free DMEM containing 5 lg/ml insulin, 1 lg/ml hydrocortisone, 0.3 lg/ml prolactin and the desired treatments as indicated in the figure legends. Where indicated, 60 ng/ml HGF and 20 lM SFTI1 was added. Media were changed every other day; cultures were kept for a period of 8-10 days and were terminated by fixation in 2% paraformaldehyde. For cultures where siRNA-transfected cells were used, additional siRNA-HiPerFect mixture was added to the culture every 3rd day. To examine the effect of SFTI1 on cell proliferation, 1000 EpH4/K6 cells were plated in each well of a 96-well plate and inhibitor was added. Media were refreshed every other day. At the end of 5-day culture, cells were stained with crystal violate, washed, dried, and the absorbance was recorded with a spectrophotometer set to 570 nm. All cultures were kept at 37°C in a 5% CO 2 atmosphere.
Western immunoblot and quantitation of chemiluminescence in gel patterns
For tissue extraction, MG were minced into small pieces and ground with a motorized pellet pestle in buffer containing 50 mM Tris-HCl (pH 7.5), 5 mM EDTA, 150 mM sodium fluoride, 10 mM b-glycerol phosphate, 10 mM sodium orthovanadate, 10 lg/ml aprotinin, and 1% Triton X-100 as described previously (Lee et al., 2000b) . Tissue extracts were clarified by centrifugation at 14,000g for 15 min and the soluble fractions were collected. EpH4/K6 cells grown to confluence were collected by centrifugation and lysed with buffer containing 50 mM Tris-HCl (pH7.5), 5 mM EDTA and 1% Triton X-100. Cell extracts were clarified by centrifugation at 10,000g for 10 min, the soluble fractions were collected. Protein concentration of the cell lysates or tissue extracts was determined by BCA TM protein assay kit (Pierce, Rochford, IL) using bovine serum albumin as a standard. Tissue samples from eight animals of 3-week old and at least five animals for the other developmental stages were taken for these studies. For each age point, an equal amount of total protein isolated from each animal was pooled together. Pooled tissue extracts or cell lysates were boiled in SDS sample buffer with or without 2-mecaptoethanol (2-ME) as indicated in the figure legends; an equal amount of protein was subjected to SDS-PAGE and followed by Western immunoblot following a procedure described previously (Lee et al., 2000b) . For quantitation of chemiluminescence in gel pattern, X-ray films from Western immunoblots were scanned with a Biorad computing densitometer, and the integrated absorbance corresponding to the area of Epi/MTP and CK8/18 was recorded. The corresponding absorbance of Epi/MTP and CK8/18 were adjusted to that of loading marker a-actin. Only the protein bands within the linear range of the X-ray film exposure were taken into quantitative measurement. The graph in Fig. 4B shows values of the area corresponding to Epi/MTP divided by the area corresponding to CK8/18 after normalization to the value for the 3-week age point.
Fluorescence immunostaining, confocal microscopy, and morphological analysis of cells grown on ECMatrix gel
Mammary epithelial cells cultured on the ECMatrix layer were fixed at room temperature for 30 min. Fixed cultures were washed three times with PBS and then permeabilized with 0.5% Triton X-100. After washing, cultures were incubated with 4% BSA for 1 h, and then with rat anti-mouse Ecadherin antibody for 2 h. Unbound antibody was removed by three changes of PBS; the bound antibody was detected by incubating with FITC-conjugated secondary antibody. Cell nuclei were counterstained with propidium iodide (Sigma). Three-dimensional cultures were imaged with Olympus IX-70 laser confocal scanning microscope and images acquired using Olympus Fluoview 300 (or 500) version 3C acquisition software. Images were collected in Z-stacks at 2 lm intervals. Three-dimensional images were reconstructed and analyzed morphometrically with MetaMorph software (Universal Imaging Corp.). Cell colonies were semi-quantitatively evaluated using the ratio of each type of colony to the total number of colonies. A total of 250-400 colonies for each treatment were counted. Six types of colony were classified based on previously published morphological features (Niemann et al., 1998) (Lee et al., 2000a) . ''Small aggregates without lumen'' are colonies smaller than 50 lm in diameter; ''large aggregates without lumen'' are colonies greater than 50 lm in diameter; ''aggregates with lumen'' are spheroids containing lumen structure in the center, they are mostly colonies with a diameter greater than 60 lm; ''multilobules'' are alveolarlike clusters without an obvious ductal projection (example of this type of colony was shown in Fig. 6E) ; ''lobules with ducts'' are single spheroids with projecting ducts or multiple lobules connected by ducts (example of this type of colony was shown in Fig. 6C, D and F) ; ''long tubular structures'' refers to colonies with tubules longer than 250 lm and often contained end-bud like structures (example of this type of colony was shown in Fig. 6B ).
